carbonthatcarbonthat
← Every company

Who Owns Nektar Therapeutics

Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Nektar Therapeutics.

Who crossed 5% of NKTR →
Managers holding
3
as of 2026-09-30
Reported value
$202.6M
summed across filings
Shares held
3.3M
Added vs trimmed
3 / 0
since each filer's last quarter

Positions as of 2026-09-30

Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.

ManagerValue
Two Seas Capital LPCOM NEW3.3M shadded$202.6M
GAMMA Investing LLCCommon Stock257 shadded$15.6K
Farther Finance Advisors, LLCStock30 shadded$1.8K

Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.

More on NKTR

Company overviewEverything on NKTR in one place, with the price.SEC filingsWhat NKTR's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat NKTR's own officers and directors buy and sell.Executive payWhat NKTR awarded its chief executive, and what it became.Funds holding itWhich funds and ETFs hold NKTR, and how big a bet.PatentsWhat NKTR is filing at the patent office.

Follow Nektar Therapeutics (NKTR) by email

New trades in Nektar Therapeutics (NKTR) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.